Virulence And Antibiotic Resistance In Group A Streptococcus: Pathogenesis And Public Health Perspective

Streptococcus pyogenes (Group A Streptococcus, GAS) continues to be a significant pathogen that causes a number of illnesses, from minor to severe invasive pharyngitis. This study examined the relation between virulence gene profiles and antimicrobial resistance in 150 clinical S. pyogenes isolates. Molecular characterization identified emm1 (28.0%) and emm12 (18.7%) as the predominant emm types, both significantly associated with invasive presentations (p = 0.014). Virulence gene analysis revealed high frequencies of slo (91.3%), scpA (84.7%), and spyCEP (76.0%), indicating widespread immune-evasive and cytotoxic potential. Every isolate was vulnerable to penicillin. G, but resistance was observed against tetracycline (33.3%), erythromycin (26.7%), and clindamycin (22.0%), raising therapeutic concerns, especially for penicillin-allergic patients. Among macrolide-resistant isolates, ermB (61.0%) and mefA (33.0%) were predominant, while tetM was detected in 85.0% of tetracycline-resistant strains. Multidrug resistance (MDR), well-defined as resistance to ≥1 agent in ≥3 antibiotic classes, was observed in 18.7% of isolates. A substantial association (p = 0.008) was found between MDR status and higher virulence gene burden (≥5 genes). speA (p = 0.016) and spyCEP (p = 0.043) were suggestively overrepresented in MDR strains, suggesting a convergence of pathogenicity and resistance determinants. These findings highlight the status of integrated molecular surveillance and advocate for real-time monitoring of virulence and resistance evolution to inform empirical therapy and guide future vaccine strategies.